ArticleFrontiers in pharmacology2020

Choosing PD-1 Inhibitors in Oncology Setting, Left or Right?-Lessons From Value Assessment With ASCO-VF and ESMO-MCBS.

Qian Jiang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.